The Orphan Drug Act (ODA) defines a rare disease as a disease or condition that affects less than 200,000 people in the United States (1). According to the European Union (EU), a rare disease is one that affects no more…
The Orphan Drug Act (ODA) defines a rare disease as a disease or condition that affects less than 200,000 people in the United States (1). According to the European Union (EU), a rare disease is one that affects no more…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.